D.A. Davidson & Co’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,650
| Closed | -$17K | – | 954 |
|
|
2020
Q2 | $17K | Buy |
1,650
+300
| +22% | +$3.09K | ﹤0.01% | 928 |
|
|
2020
Q1 | $8K | Hold |
1,350
| – | – | ﹤0.01% | 979 |
|
|
2019
Q4 | $9K | Hold |
1,350
| – | – | ﹤0.01% | 1004 |
|
|
2019
Q3 | $9K | Hold |
1,350
| – | – | ﹤0.01% | 1000 |
|
|
2019
Q2 | $10K | Sell |
1,350
-1,083
| -45% | -$8.02K | ﹤0.01% | 989 |
|
|
2019
Q1 | $35K | Hold |
2,433
| – | – | ﹤0.01% | 1128 |
|
|
2018
Q4 | $28K | Hold |
2,433
| – | – | ﹤0.01% | 1085 |
|
|
2018
Q3 | $54K | Buy |
2,433
+500
| +26% | +$11.1K | ﹤0.01% | 1148 |
|
|
2018
Q2 | $37K | Hold |
1,933
| – | – | ﹤0.01% | 1109 |
|
|
2018
Q1 | $21K | Sell |
1,933
-3,300
| -63% | -$35.9K | ﹤0.01% | 1095 |
|
|
2017
Q4 | $104K | Buy |
5,233
+3,633
| +227% | +$72.2K | ﹤0.01% | 1076 |
|
|
2017
Q3 | $27K | Sell |
1,600
-2,667
| -63% | -$45K | ﹤0.01% | 1073 |
|
|
2017
Q2 | $156K | Hold |
4,267
| – | – | ﹤0.01% | 1064 |
|
|
2017
Q1 | $193K | Buy |
4,267
+534
| +14% | +$24.2K | ﹤0.01% | 953 |
|
|
2016
Q4 | $98K | Sell |
3,733
-500
| -12% | -$13.1K | ﹤0.01% | 1311 |
|
|
2016
Q3 | $171K | Buy |
4,233
+1,233
| +41% | +$49.8K | ﹤0.01% | 1002 |
|
|
2016
Q2 | $159K | Hold |
3,000
| – | – | ﹤0.01% | 928 |
|
|
2016
Q1 | $179K | Buy |
3,000
+1,333
| +80% | +$79.5K | 0.01% | 883 |
|
|
2015
Q4 | $161K | Buy |
+1,667
| New | +$161K | 0.01% | 921 |
|